{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:08:19Z","timestamp":1782511699855,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR071734"],"award-info":[{"award-number":["R01AR071734"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-13-1-0465"],"award-info":[{"award-number":["W81XWH-13-1-0465"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["TRAN1-09288"],"award-info":[{"award-number":["TRAN1-09288"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Heart and Lung Foundation","award":["20140448"],"award-info":[{"award-number":["20140448"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2016-01381"],"award-info":[{"award-number":["2016-01381"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"KID-funding from the Karolinska Institutet","award":["2415\/2012-225"],"award-info":[{"award-number":["2415\/2012-225"]}]},{"name":"KID-funding from the Karolinska Institutet","award":["2-3707\/2013"],"award-info":[{"award-number":["2-3707\/2013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00109-018-1680-3","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T18:54:05Z","timestamp":1533668045000},"page":"1049-1060","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Genetic ablation of adenosine receptor A3 results in articular cartilage degeneration"],"prefix":"10.1007","volume":"96","author":[{"given":"Ruzanna","family":"Shkhyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Peleli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Carlstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei S.","family":"Chagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Limfat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Q.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Evseenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"issue":"3","key":"1680_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.semarthrit.2016.07.013","volume":"46","author":"E Yelin","year":"2016","unstructured":"Yelin E, Weinstein S, King T (2016) The burden of musculoskeletal diseases in the United States. Semin Arthritis Rheum 46(3):259\u2013260","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"1680_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1063-4584(05)80007-X","volume":"2","author":"H Muller-Fassbender","year":"1994","unstructured":"Muller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I (1994) Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthr Cartil 2(1):61\u201369","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"1680_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1242\/dev.052324","volume":"138","author":"Y Li","year":"2011","unstructured":"Li Y, Ahrens MJ, Wu A, Liu J, Dudley AT (2011) Calcium\/calmodulin-dependent protein kinase II activity regulates the proliferative potential of growth plate chondrocytes. Development 138(2):359\u2013370","journal-title":"Development"},{"issue":"2","key":"1680_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3892\/etm.2015.2937","volume":"11","author":"W Liang","year":"2016","unstructured":"Liang W, Li X, Gao B, Gan H, Lin X, Liao L et al (2016) Observing the development of the temporomandibular joint in embryonic and post-natal mice using various staining methods. Exp Ther Med 11(2):481\u2013489","journal-title":"Exp Ther Med"},{"issue":"5","key":"1680_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/ar3117","volume":"12","author":"R Dreier","year":"2010","unstructured":"Dreier R (2010) Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders. Arthritis Res Ther 12(5):216","journal-title":"Arthritis Res Ther"},{"key":"1680_CR6","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1038\/s41598-017-02490-w","volume":"7","author":"L Liao","year":"2017","unstructured":"Liao L, Zhang S, Gu J, Takarada T, Yoneda Y, Huang J, Zhao L, Oh CD, Li J, Wang B, Wang M, Chen D (2017) Deletion of Runx2 in articular chondrocytes decelerates the progression of DMM-induced osteoarthritis in adult mice. Sci Rep 7:2371","journal-title":"Sci Rep"},{"issue":"1","key":"1680_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-015-0404-3","volume":"14","author":"KA Cohen-Solal","year":"2015","unstructured":"Cohen-Solal KA, Boregowda RK, Lasfar A (2015) RUNX2 and the PI3K\/AKT axis reciprocal activation as a driving force for tumor progression. Mol Cancer 14(1):137","journal-title":"Mol Cancer"},{"issue":"6","key":"1680_CR8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ajpath.2013.08.024","volume":"183","author":"P Fern\u00e1ndez","year":"2013","unstructured":"Fern\u00e1ndez P, Perez-Aso M, Smith G, Wilder T, Trzaska S, Chiriboga L, Franks A Jr, Robson SC, Cronstein BN, Chan ESL (2013) Extracellular generation of adenosine by the ectonucleotidases CD39 and CD73 promotes dermal fibrosis. Am J Pathol 183(6):1740\u20131746","journal-title":"Am J Pathol"},{"issue":"10","key":"1680_CR9","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1093\/rheumatology\/ket205","volume":"52","author":"F Gullo","year":"2013","unstructured":"Gullo F, De Bari C (2013) Prospective purification of a subpopulation of human synovial mesenchymal stem cells with enhanced chondro-osteogenic potency. Rheumatology (Oxford) 52(10):1758\u20131768","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1680_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.joca.2004.01.002","volume":"12","author":"AM Tesch","year":"2004","unstructured":"Tesch AM, MacDonald MH, Kollias-Baker C, Benton HP (2004) Endogenously produced adenosine regulates articular cartilage matrix homeostasis: enzymatic depletion of adenosine stimulates matrix degradation. Osteoarthr Cartil 12(5):349\u2013359","journal-title":"Osteoarthr Cartil"},{"key":"1680_CR11","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1038\/ncomms15019","volume":"8","author":"C Corciulo","year":"2017","unstructured":"Corciulo C, Lendhey M, Wilder T, Schoen H, Cornelissen AS, Chang G, Kennedy OD, Cronstein BN (2017) Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression. Nat Commun 8:15019","journal-title":"Nat Commun"},{"issue":"4","key":"1680_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrd3955","volume":"12","author":"JF Chen","year":"2013","unstructured":"Chen JF, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets\u2014what are the challenges? Nat Rev Drug Discov 12(4):265\u2013286","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"1680_CR13","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/0006-2952(92)90616-Q","volume":"43","author":"JW Daly","year":"1992","unstructured":"Daly JW, Padgett WL (1992) Agonist activity of 2- and 5\u2032-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate cyclase. Biochem Pharmacol 43(5):1089\u20131093","journal-title":"Biochem Pharmacol"},{"issue":"7\u20138","key":"1680_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.drudis.2011.10.007","volume":"17","author":"P Fishman","year":"2012","unstructured":"Fishman P, Bar-Yehuda S, Liang BT, Jacobson KA (2012) Pharmacological and therapeutic effects of A3 adenosine receptor agonists. Drug Discov Today 17(7\u20138):359\u2013366","journal-title":"Drug Discov Today"},{"issue":"2","key":"1680_CR15","first-page":"287","volume":"33","author":"S Bar-Yehuda","year":"2008","unstructured":"Bar-Yehuda S, Stemmer SM, Madi L, Castel D, Ochaion A, Cohen S, Barer F, Zabutti A, Perez-Liz G, del Valle L, Fishman P (2008) The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways. Int J Oncol 33(2):287\u2013295","journal-title":"Int J Oncol"},{"issue":"3A","key":"1680_CR16","first-page":"2077","volume":"23","author":"P Fishman","year":"2003","unstructured":"Fishman P, Bar-Yehuda S, Ardon E, Rath-Wolfson L, Barrer F, Ochaion A, Madi L (2003) Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist. Anticancer Res 23(3A):2077\u20132083","journal-title":"Anticancer Res"},{"issue":"12","key":"1680_CR17","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/S0301-472X(02)00962-1","volume":"30","author":"S Bar-Yehuda","year":"2002","unstructured":"Bar-Yehuda S, Madi L, Barak D, Mittelman M, Ardon E, Ochaion A, Cohn S, Fishman P (2002) Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents. Exp Hematol 30(12):1390\u20131398","journal-title":"Exp Hematol"},{"issue":"7","key":"1680_CR18","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ophtha.2009.11.029","volume":"117","author":"I Avni","year":"2010","unstructured":"Avni I, Garzozi HJ, Barequet IS, Segev F, Varssano D, Sartani G, Chetrit N, Bakshi E, Zadok D, Tomkins O, Litvin G, Jacobson KA, Fishman S, Harpaz Z, Farbstein M, Yehuda SB, Silverman MH, Kerns WD, Bristol DR, Cohn I, Fishman P (2010) Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial. Ophthalmology 117(7):1287\u20131293","journal-title":"Ophthalmology"},{"issue":"1","key":"1680_CR19","first-page":"41","volume":"35","author":"MH Silverman","year":"2008","unstructured":"Silverman MH, Strand V, Markovits D, Nahir M, Reitblat T, Molad Y, Rosner I, Rozenbaum M, Mader R, Adawi M, Caspi D, Tishler M, Langevitz P, Rubinow A, Friedman J, Green L, Tanay A, Ochaion A, Cohen S, Kerns WD, Cohn I, Fishman-Furman S, Farbstein M, Yehuda SB, Fishman P (2008) Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. J Rheumatol 35(1):41\u201348","journal-title":"J Rheumatol"},{"issue":"10","key":"1680_CR20","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/art.24817","volume":"60","author":"S Bar-Yehuda","year":"2009","unstructured":"Bar-Yehuda S, Rath-Wolfson L, Del Valle L, Ochaion A, Cohen S, Patoka R et al (2009) Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment. Arthritis Rheum 60(10):3061\u20133071","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1680_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1021\/jm00031a014","volume":"37","author":"C Gallo-Rodriguez","year":"1994","unstructured":"Gallo-Rodriguez C, Ji XD, Melman N, Siegman BD, Sanders LH, Orlina J, Fischer B, Pu Q, Olah ME, van Galen P (1994) Structure-activity relationships of N6-benzyladenosine-5\u2032-uronamides as A3-selective adenosine agonists. J Med Chem 37(5):636\u2013646","journal-title":"J Med Chem"},{"issue":"4\u20135","key":"1680_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s002100000315","volume":"362","author":"KN Klotz","year":"2000","unstructured":"Klotz KN (2000) Adenosine receptors and their ligands. Naunyn Schmiedeberg's Arch Pharmacol 362(4\u20135):382\u2013391","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"7","key":"1680_CR23","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.neuropharm.2004.01.014","volume":"46","author":"L Halldner","year":"2004","unstructured":"Halldner L, \u00c5d\u00e9n U, Dahlberg V, Johansson B, Ledent C, Fredholm BB (2004) The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and\/or A2A receptors. Neuropharmacology 46(7):1008\u20131017","journal-title":"Neuropharmacology"},{"key":"1680_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3389\/fphys.2015.00222","volume":"6","author":"M Peleli","year":"2015","unstructured":"Peleli M, Hezel M, Zollbrecht C, Persson AEG, Lundberg JO, Weitzberg E et al (2015) In adenosine A(2B) knockouts acute treatment with inorganic nitrate improves glucose disposal, oxidative stress, and AMPK signaling in the liver. Front Physiol 6:222","journal-title":"Front Physiol"},{"issue":"7","key":"1680_CR25","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1007\/s00125-015-3570-3","volume":"58","author":"T Yang","year":"2015","unstructured":"Yang T, Gao X, Sandberg M, Zollbrecht C, Zhang X-M, Hezel M, Liu M, Peleli M, Lai EY, Harris RA, Persson AEG, Fredholm BB, Jansson L, Carlstr\u00f6m M (2015) Abrogation of adenosine A1 receptor signalling improves metabolic regulation in mice by modulating oxidative stress and inflammatory responses. Diabetologia 58(7):1610\u20131620","journal-title":"Diabetologia"},{"issue":"7","key":"1680_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003868","volume":"5","author":"T Yang","year":"2016","unstructured":"Yang T, Zollbrecht C, Winerdal ME, Zhuge Z, Zhang XM, Terrando N, Checa A, S\u00e4llstr\u00f6m J, Wheelock CE, Winqvist O, Harris RA, Larsson E, Persson AEG, Fredholm BB, Carlstr\u00f6m M (2016) Genetic abrogation of adenosine A(3) receptor prevents uninephrectomy and high salt\u2013induced hypertension. J Am Heart Assoc: Cardiovascular and Cerebrovascular Disease 5(7):e003868","journal-title":"J Am Heart Assoc: Cardiovascular and Cerebrovascular Disease"},{"issue":"1","key":"1680_CR27","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1186\/ar4133","volume":"15","author":"M Wang","year":"2013","unstructured":"Wang M, Sampson ER, Jin H, Li J, Ke QH, Im H-J et al (2013) MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther 15(1):R5 -R","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"1680_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/joca.2001.0427","volume":"9","author":"MD Tortorella","year":"2001","unstructured":"Tortorella MD, Malfait AM, Deccico C, Arner E (2001) The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthr Cartil 9(6):539\u2013552","journal-title":"Osteoarthr Cartil"},{"key":"1680_CR29","doi-asserted-by":"crossref","unstructured":"Quinn C. Parathyroid hormone induces rat interstitial collagenase mRNA through Ets-1 facilitated by cyclic AMP response element-binding protein and Ca(2+)\/calmodulin-dependent protein kinase II in osteoblastic cells 2000. 73\u201384","DOI":"10.1677\/jme.0.0250073"},{"issue":"12","key":"1680_CR30","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.joca.2004.08.008","volume":"12","author":"X Wang","year":"2004","unstructured":"Wang X, Manner PA, Horner A, Shum L, Tuan RS, Nuckolls GH (2004) Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthr Cartil 12(12):963\u2013973","journal-title":"Osteoarthr Cartil"},{"key":"1680_CR31","doi-asserted-by":"publisher","first-page":"561459","DOI":"10.1155\/2014\/561459","volume":"2014","author":"P Wojdasiewicz","year":"2014","unstructured":"Wojdasiewicz P, Poniatowski LA, Szukiewicz D (2014) The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat Inflamm 2014:561459","journal-title":"Mediat Inflamm"},{"issue":"10","key":"1680_CR32","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1073\/pnas.1419699112","volume":"112","author":"S Sugita","year":"2015","unstructured":"Sugita S, Hosaka Y, Okada K, Mori D, Yano F, Kobayashi H, Taniguchi Y, Mori Y, Okuma T, Chang SH, Kawata M, Taketomi S, Chikuda H, Akiyama H, Kageyama R, Chung UI, Tanaka S, Kawaguchi H, Ohba S, Saito T (2015) Transcription factor Hes1 modulates osteoarthritis development in cooperation with calcium\/calmodulin-dependent protein kinase 2. Proc Natl Acad Sci U S A 112(10):3080\u20133085","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1680_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11302-015-9459-2","volume":"11","author":"DK Tosh","year":"2015","unstructured":"Tosh DK, Padia J, Salvemini D, Jacobson KA (2015) Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain. Purinergic Signal 11(3):371\u2013387","journal-title":"Purinergic Signal"},{"issue":"4","key":"1680_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/ard.2006.053272","volume":"65","author":"M Grunke","year":"2006","unstructured":"Grunke M, Schulze-Koops H (2006) Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann Rheum Dis 65(4):555\u2013556","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1680_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jcp.1041540208","volume":"154","author":"JPG Urban","year":"1993","unstructured":"Urban JPG, Hall AC, Gehl KA (1993) Regulation of matrix synthesis rates by the ionic and osmotic environment of articular chondrocytes. J Cell Physiol 154(2):262\u2013270","journal-title":"J Cell Physiol"},{"issue":"4","key":"1680_CR36","first-page":"487","volume":"22","author":"JC Sanchez","year":"2003","unstructured":"Sanchez JC, Danks TA, Wilkins RJ (2003) Mechanisms involved in the increase in intracellular calcium following hypotonic shock in bovine articular chondrocytes. Gen Physiol Biophys 22(4):487\u2013500","journal-title":"Gen Physiol Biophys"},{"issue":"4","key":"1680_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1515\/bmc-2012-0001","volume":"3","author":"C Brocker","year":"2012","unstructured":"Brocker C, Thompson DC, Vasiliou V (2012) The role of hyperosmotic stress in inflammation and disease. Biomol Concepts 3(4):345\u2013364","journal-title":"Biomol Concepts"},{"key":"1680_CR38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/978-1-4613-1143-0_21","volume-title":"Molecular biology of membrane transport disorders","author":"WB Busa","year":"1996","unstructured":"Busa WB (1996) Regulation of intracellular free calcium. In: Schultz SG, Andreoli TE, Brown AM, Fambrough DM, Hoffman JF, Welsh MJ (eds) Molecular biology of membrane transport disorders. Springer US, Boston, MA, pp 427\u2013446"},{"key":"1680_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1757-7241-21-86","volume":"21","author":"WZ Martini","year":"2013","unstructured":"Martini WZ, Cortez DS, Dubick MA (2013) Comparisons of normal saline and lactated Ringer\u2019s resuscitation on hemodynamics, metabolic responses, and coagulation in pigs after severe hemorrhagic shock. Scand J Trauma Resusc Emerg Med 21:86","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"7226","key":"1680_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nature07475","volume":"457","author":"S Rebouissou","year":"2009","unstructured":"Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P, Zucman-Rossi J (2009) Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457(7226):200\u2013204","journal-title":"Nature"},{"issue":"4","key":"1680_CR41","first-page":"400","volume":"24","author":"L Rath-Wolfson","year":"2006","unstructured":"Rath-Wolfson L, Bar-Yehuda S, Madi L, Ochaion A, Cohen S, Zabutti A, Fishman P (2006) IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis. Clin Exp Rheumatol 24(4):400\u2013406","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"1680_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11302-016-9527-2","volume":"12","author":"LC Strazzulla","year":"2016","unstructured":"Strazzulla LC, Cronstein BN (2016) Regulation of bone and cartilage by adenosine signaling. Purinergic Signalling 12(4):583\u2013593","journal-title":"Purinergic Signalling"},{"issue":"12","key":"1680_CR43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3727\/000000007783629981","volume":"16","author":"M Panjehpour","year":"2007","unstructured":"Panjehpour M, Karami-Tehrani F (2007) Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors. Oncol Res 16(12):575\u2013585","journal-title":"Oncol Res"},{"issue":"12","key":"1680_CR44","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/j.1600-6143.2004.00620.x","volume":"4","author":"J Rivo","year":"2004","unstructured":"Rivo J, Zeira E, Galun E, Matot I (2004) Activation of A3 adenosine receptor provides lung protection against ischemia-reperfusion injury associated with reduction in apoptosis. Am J Transplant 4(12):1941\u20131948","journal-title":"Am J Transplant"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-018-1680-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1680-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1680-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T16:46:06Z","timestamp":1589561166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-018-1680-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1680"],"URL":"https:\/\/doi.org\/10.1007\/s00109-018-1680-3","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,7]]},"assertion":[{"value":"6 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments were approved by the institutional review board (the Stockholm Ethical Committee for Animal Experiments; Protocols: N139\/15 & N314\/12) and were conducted in accordance with the National Institutes of Health guidelines for the conduct of experiments in animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}